156 related articles for article (PubMed ID: 32248212)
1. Tumor microenvironment and NIR laser dual-responsive release of berberine 9-O-pyrazole alkyl derivative loaded in graphene oxide nanosheets for chemo-photothermal synergetic cancer therapy.
Du P; Yan J; Long S; Xiong H; Wen N; Cai S; Wang Y; Peng D; Liu Z; Liu Y
J Mater Chem B; 2020 May; 8(18):4046-4055. PubMed ID: 32248212
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract][Full Text] [Related]
3. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-functionalized molybdenum disulfide nanosheets for tumor cell targeting and lysosomal acidic environment/NIR laser responsive drug delivery to realize synergetic chemo-photothermal therapeutic effects.
Cai S; Yan J; Xiong H; Wu Q; Xing H; Liu Y; Liu S; Liu Z
Int J Pharm; 2020 Nov; 590():119948. PubMed ID: 33031876
[TBL] [Abstract][Full Text] [Related]
5. Zwitterion-functionalized hollow mesoporous Prussian blue nanoparticles for targeted and synergetic chemo-photothermal treatment of acute myeloid leukemia.
Bai H; Sun Q; Kong F; Dong H; Ma M; Liu F; Wang C; Xu H; Gu N; Zhang Y
J Mater Chem B; 2021 Jul; 9(26):5245-5254. PubMed ID: 34095945
[TBL] [Abstract][Full Text] [Related]
6. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
[TBL] [Abstract][Full Text] [Related]
7. Palladium nanoparticle-decorated 2-D graphene oxide for effective photodynamic and photothermal therapy of prostate solid tumors.
Thapa RK; Soe ZC; Ou W; Poudel K; Jeong JH; Jin SG; Ku SK; Choi HG; Lee YM; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Sep; 169():429-437. PubMed ID: 29843117
[TBL] [Abstract][Full Text] [Related]
8. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
[TBL] [Abstract][Full Text] [Related]
10. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
11. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment Responsive Shape-Reversal Self-Targeting Virus-Inspired Nanodrug for Imaging-Guided Near-Infrared-II Photothermal Chemotherapy.
Li Y; Lin J; Wang P; Luo Q; Lin H; Zhang Y; Hou Z; Liu J; Liu X
ACS Nano; 2019 Nov; 13(11):12912-12928. PubMed ID: 31651142
[TBL] [Abstract][Full Text] [Related]
13. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment.
Thapa RK; Kim JH; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 May; 153():95-103. PubMed ID: 28231500
[TBL] [Abstract][Full Text] [Related]
14. "Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.
Chauhan G; Chopra V; Tyagi A; Rath G; Sharma RK; Goyal AK
Eur J Pharm Sci; 2017 Jan; 96():351-361. PubMed ID: 27721039
[TBL] [Abstract][Full Text] [Related]
15. Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).
Guo W; Chen Z; Feng X; Shen G; Huang H; Liang Y; Zhao B; Li G; Hu Y
J Nanobiotechnology; 2021 May; 19(1):146. PubMed ID: 34011375
[TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
17. A hollow-structured nanohybrid: Intelligent and visible drug delivery and photothermal therapy for cancer.
Yang L; Hu B; Liu AH; Zhang Y
Talanta; 2020 Aug; 215():120893. PubMed ID: 32312438
[TBL] [Abstract][Full Text] [Related]
18. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
19. Photothermal effect and cytotoxicity of CuS nanoflowers deposited over folic acid conjugated nanographene oxide.
Neelgund GM; Oki A; Bandara S; Carson L
J Mater Chem B; 2021 Feb; 9(7):1792-1803. PubMed ID: 33393530
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Nanosystem Based on Graphene Oxide for Synergistic Multistage Tumor-Targeting and Combined Chemo-Photothermal Therapy.
Zhang H; Li Y; Pan Z; Chen Y; Fan Z; Tian H; Zhou S; Zhang Y; Shang J; Jiang B; Wang F; Luo F; Hou Z
Mol Pharm; 2019 May; 16(5):1982-1998. PubMed ID: 30892898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
